AMP Biopharma Ventures announces today, the initial trades into its $1,000,000 biopharma model portfolio. For in-depth analysis on these companies click on the company links below.*
FGEN - $25,000
NKTR - $25,000
ALKS - $25,000
QURE - $20,000
OPTH - $20,000
CYTR - $10,000
*This blog posting has been prepared by AMP Biopharma Ventures (“ABV”). This document is for information and illustrative purposes only and does not purport to show actual trades or results. It is not, and should not be regarded as investment or legal advice or as a recommendation regarding any particular security or course of action. Investment opinions expressed herein are current opinions as of the date appearing in this material only and are subject to change without notice. Reasonable people may disagree about the opinions expressed herein. In the event any of the assumptions used herein do not prove to be true, results are likely to vary substantially. All investments entail risks. There is no guarantee that investment strategies will achieve the desired results under all market conditions and each investor should evaluate its ability to invest for a long term especially during periods of a market downturn. No representation is being made that any account, product, or strategy will or is likely to achieve profits, losses, or results similar to those discussed, if any. No part of this document may be reproduced in any manner, in whole or in part, without the prior written permission of ABV. This information is provided with the understanding that with respect to the material provided herein, that you will make your own independent decision with respect to any course of action in connection herewith and as to whether such course of action is appropriate or proper based on your own judgment, and that you are capable of understanding and assessing the merits of a course of action. ABV does not purport to and does not, in any fashion, provide tax, accounting, actuarial, recordkeeping, legal, broker/dealer or any related services. You may not rely on the statements contained herein. ABV shall not have any liability for any damages of any kind whatsoever relating to this material. You should consult your advisors with respect to these areas. By accepting this material, you acknowledge, understand and accept the foregoing.